5.59
price up icon2.95%   0.16
after-market アフターアワーズ: 5.59
loading
前日終値:
$5.43
開ける:
$5.46
24時間の取引高:
3.26M
Relative Volume:
1.24
時価総額:
$833.22M
収益:
-
当期純損益:
$-134.24M
株価収益率:
-3.1582
EPS:
-1.77
ネットキャッシュフロー:
$-121.34M
1週間 パフォーマンス:
+9.82%
1か月 パフォーマンス:
-7.45%
6か月 パフォーマンス:
+160.00%
1年 パフォーマンス:
+126.32%
1日の値動き範囲:
Value
$5.37
$5.64
1週間の範囲:
Value
$4.96
$5.73
52週間の値動き範囲:
Value
$1.285
$7.18

Annexon Inc Stock (ANNX) Company Profile

Name
名前
Annexon Inc
Name
セクター
Healthcare (1106)
Name
電話
(650) 822-5500
Name
住所
1400 SIERRA POINT PARKWAY, BRISBANE
Name
職員
99
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
ANNX's Discussions on Twitter

Compare ANNX vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ANNX
Annexon Inc
5.59 809.37M 0 -134.24M -121.34M -1.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.89 120.48B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
787.50 81.05B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
749.56 46.33B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.30 42.26B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.02 32.87B 5.36B 287.73M 924.18M 2.5229

Annexon Inc Stock (ANNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-23 開始されました Chardan Capital Markets Buy
2024-03-01 アップグレード JP Morgan Neutral → Overweight
2023-12-21 アップグレード BofA Securities Neutral → Buy
2023-10-30 開始されました Wells Fargo Overweight
2023-05-26 ダウングレード BofA Securities Buy → Neutral
2023-05-25 ダウングレード JP Morgan Overweight → Neutral
2022-09-16 開始されました Jefferies Buy
2022-09-09 開始されました BTIG Research Buy
2021-11-30 開始されました H.C. Wainwright Buy
2021-09-23 開始されました Cantor Fitzgerald Overweight
2021-01-26 開始されました Needham Buy
2020-08-18 開始されました BofA Securities Buy
2020-08-18 開始されました Cowen Outperform
2020-08-18 開始されました JP Morgan Overweight
すべてを表示

Annexon Inc (ANNX) 最新ニュース

pulisher
Mar 04, 2026

Annexon (ANNX) CFO Lew sells shares to cover RSU tax withholding - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Annexon, Inc. (ANNX) CMO sells shares to cover tax obligations - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Annexon (ANNX) EVP Overdorf sells shares to cover RSU tax - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Annexon (ANNX) EVP sells 5,566 shares to cover RSU tax withholding - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Annexon Spotlights GA Phase III, GBS Regulatory Plans and ANX1502 Update at TD Cowen Conference - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

ANNX: Late-stage neuroinflammatory programs near key data and filings, with strong commercial focus - TradingView

Mar 03, 2026
pulisher
Mar 02, 2026

Director files sale notice for 5,566 ANNX shares (NASDAQ: ANNX) - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

ANNX (NASDAQ: ANNX) Rule 144 notice shows 5,894 shares to be sold; prior 5,290 sold - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

ANNX (NASDAQ) Rule 144: Insider sale of 6,225 shares; 4,339 vested - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

ANNX (NASDAQ: ANNX) Form 144 lists 5,565-share notice and recent insider sale - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

ANNX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 01, 2026
pulisher
Feb 28, 2026

Annexon Showcases Promising Drug Ahead of Pivotal Trial Data - StocksToTrade

Feb 28, 2026
pulisher
Feb 28, 2026

Annexon Showcases Emerging Treatment with Topline Data on Horizon - timothysykes.com

Feb 28, 2026
pulisher
Feb 27, 2026

ANNX Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 27, 2026
pulisher
Feb 27, 2026

Annexon Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView

Feb 27, 2026
pulisher
Feb 27, 2026

Does Annexon Inc. meet Warren Buffett’s criteriaEarnings Performance Report & Weekly Watchlist for Consistent Profits - mfd.ru

Feb 27, 2026
pulisher
Feb 27, 2026

ANNX (NASDAQ: ANNX) insider sale notice: 5,820 shares tied to vesting - Stock Titan

Feb 27, 2026
pulisher
Feb 24, 2026

Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference - Investing News Network

Feb 24, 2026
pulisher
Feb 23, 2026

Annexon (ANNX) CFO receives 250,000 options and 62,500 RSUs in equity grant - Stock Titan

Feb 23, 2026
pulisher
Feb 23, 2026

Annexon (ANNX) grants CMO 225,000 options and 56,250 RSUs - Stock Titan

Feb 23, 2026
pulisher
Feb 20, 2026

Jamie Dananberg Sells 5,290 Shares of Annexon (NASDAQ:ANNX) Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Insider Selling: Annexon (NASDAQ:ANNX) EVP Sells 5,290 Shares of Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Annexon (NASDAQ:ANNX) EVP Sells $40,149.27 in Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Annexon (NASDAQ:ANNX) CFO Sells $40,118.61 in Stock - MarketBeat

Feb 20, 2026
pulisher
Feb 20, 2026

Annexon (ANNX) EVP sells 7,857 shares to cover RSU tax withholding - Stock Titan

Feb 20, 2026
pulisher
Feb 20, 2026

Will Annexon Inc benefit from government policyTrade Volume Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

Aug Spikes: Will Annexon Inc benefit from government policyJuly 2025 PreEarnings & Technical Pattern Based Signals - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

Published on: 2026-02-21 08:39:55 - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 20, 2026

Is Annexon Inc stock a good dividend stock2025 Biggest Moves & High Return Trade Opportunity Guides - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 18, 2026

[144] Annexon, Inc. SEC Filing - Stock Titan

Feb 18, 2026
pulisher
Feb 17, 2026

Annexon Biosciences Announces Planned Retirement of Board Chairman - TipRanks

Feb 17, 2026
pulisher
Feb 17, 2026

Annexon, Inc. Announces Retirement of Chairman of the Board Thomas G. Wiggans - marketscreener.com

Feb 17, 2026
pulisher
Feb 17, 2026

Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy - The Manila Times

Feb 17, 2026
pulisher
Feb 16, 2026

Annexon Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - Quantisnow

Feb 16, 2026
pulisher
Feb 11, 2026

FMR LLC Reduces Stake in Annexon Inc: A Strategic Portfolio Adju - GuruFocus

Feb 11, 2026
pulisher
Feb 10, 2026

Aug Decliners: What are the risks of holding Annexon IncJuly 2025 WrapUp & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Feb 10, 2026
pulisher
Feb 07, 2026

A Pivotal Year Ahead for Annexon’s Clinical Ambitions - AD HOC NEWS

Feb 07, 2026
pulisher
Feb 05, 2026

Annexon, Inc. (NASDAQ:ANNX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 05, 2026
pulisher
Feb 04, 2026

Macro Review: Is Annexon Inc in a bullish channel2025 Price Targets & Low Drawdown Momentum Ideas - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 02, 2026

Dow Update: Can Annexon Inc reach all time highs this yearIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 02, 2026

Market Recap: Will Annexon Inc benefit from government policyJuly 2025 Reactions & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Feb 02, 2026
pulisher
Jan 30, 2026

Breakout Watch: Will Annexon Inc benefit from government policyDay Trade & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 30, 2026

VIX Spike: Will CYBN stock recover after earnings2025 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 30, 2026

Annexon, Inc. $ANNX Stake Cut by J. Safra Sarasin Holding AG - MarketBeat

Jan 30, 2026
pulisher
Jan 28, 2026

Bank of America Securities Reaffirms Their Buy Rating on Annexon Biosciences (ANNX) - The Globe and Mail

Jan 28, 2026
pulisher
Jan 27, 2026

Investment Recap: Can HSCS sustain its profitability2025 Investor Takeaways & Daily Profit Maximizing Tips - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 25, 2026

Analyst Downgrade: Will Annexon Inc stock benefit from M AJuly 2025 PostEarnings & Real-Time Volume Triggers - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 24, 2026

Annexon Offers A High-Risk, High-Reward Play On A New Approach To Complement-Mediated Diseases - Seeking Alpha

Jan 24, 2026
pulisher
Jan 24, 2026

Annexon stock hits 52-week high at 7.1 USD By Investing.com - Investing.com Nigeria

Jan 24, 2026
pulisher
Jan 23, 2026

Annexon stock hits 52-week high at 7.1 USD - Investing.com

Jan 23, 2026

Annexon Inc (ANNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$47.43
price down icon 0.11%
$29.52
price up icon 6.00%
$57.80
price up icon 15.99%
$103.80
price up icon 3.02%
$149.88
price up icon 1.96%
biotechnology ONC
$299.02
price up icon 0.67%
大文字化:     |  ボリューム (24 時間):